Loading...
Syra Health Corp. Class A Common Stock
SYRA•NASDAQ
Healthcare
Medical - Care Facilities
$0.10
$0.02(24.39%)
Syra Health Corp. Class A Common Stock (SYRA) Financial Performance & Income Statement Overview
Review Syra Health Corp. Class A Common Stock’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
44.73%
↑ 44.73%
Operating Income Growth
-30.38%
↓ 30.38%
Net Income Growth
-27.94%
↓ 27.94%
Operating Cash Flow Growth
-6.27%
↓ 6.27%
Operating Margin
-34.55%
↓ 34.55%
Gross Margin
14.82%
↑ 14.82%
Net Profit Margin
-34.43%
↓ 34.43%
ROE
-103.53%
↓ 103.53%
ROIC
-113.74%
↓ 113.74%
Syra Health Corp. Class A Common Stock (SYRA) Income Statement & Financial Overview
Review Syra Health Corp. Class A Common Stock's (SYRA) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.007M | $2.25M | $1.97M | $1.75M |
| Cost of Revenue | $1.55M | $1.59M | $2.48M | $1.57M |
| Gross Profit | $455371.00 | $668298.00 | -$514431.00 | $179287.00 |
| Gross Profit Ratio | $0.23 | $0.30 | -$0.26 | $0.10 |
| R&D Expenses | -$5117.00 | $34821.00 | $277894.00 | $277548.00 |
| SG&A Expenses | $954878.00 | $288305.00 | $598028.00 | $1.30M |
| Operating Expenses | $957039.00 | $1.10M | $875922.00 | $1.59M |
| Total Costs & Expenses | $2.51M | $2.68M | $3.36M | $3.16M |
| Interest Income | $2799.00 | $13641.00 | $3826.00 | $981.00 |
| Interest Expense | $5528.00 | $2266.00 | $3729.00 | $4077.00 |
| Depreciation & Amortization | $7278.00 | $25541.00 | $17374.00 | $12545.00 |
| EBITDA | -$491591.00 | -$389728.00 | -$1.37M | -$1.43M |
| EBITDA Ratio | -$0.24 | -$0.17 | -$0.70 | -$0.82 |
| Operating Income | -$501668.00 | -$428910.00 | -$1.39M | -$1.44M |
| Operating Income Ratio | -$0.25 | -$0.19 | -$0.71 | -$0.82 |
| Other Income/Expenses (Net) | -$2729.00 | $11375.00 | $97.00 | -$3096.00 |
| Income Before Tax | -$504397.00 | -$417535.00 | -$1.39M | -$1.45M |
| Income Before Tax Ratio | -$0.25 | -$0.19 | -$0.71 | -$0.83 |
| Income Tax Expense | $0.00 | $0.00 | -$4.00 | $4077.00 |
| Net Income | -$504397.00 | -$417535.00 | -$1.39M | -$1.45M |
| Net Income Ratio | -$0.25 | -$0.19 | -$0.71 | -$0.83 |
| EPS | -$0.07 | -$0.06 | -$0.21 | -$0.22 |
| Diluted EPS | -$0.07 | -$0.06 | -$0.21 | -$0.22 |
| Weighted Avg Shares Outstanding | $7.26M | $7.26M | $6.60M | $6.50M |
| Weighted Avg Shares Outstanding (Diluted) | $7.26M | $7.26M | $6.60M | $6.50M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan